5 completed. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 2 | Completed 2 |
Follow amrubicin: new trials by email Literature Review of amrubicin trials Research Report on amrubicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma Amrubicin, Lenalidomide, Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Michaela Liedtke | 14 | 2011-08-01 | 2018-09-18 |
| Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer Amrubicin - Metastatic Breast Cancer | Phase 1 / Phase 2 | Completed | SCRI Development Innovations, LLC | 78 | 2009-12-01 | 2022-05-03 |
| A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors. Amrubicin - Advanced Solid Tumors | Phase 1 | Completed | Celgene | 24 | 2009-06-01 | 2019-11-01 |
| Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies Amrubicin, Cyclophosphamide - Lung Cancer | Phase 1 | Completed | Lawrence Einhorn | 36 | 2009-03-01 | 2015-12-23 |
| Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer amrubicin hydrochloride, irinotecan hydrochloride - Lung Cancer | Phase 1 | Completed | Japan Multinational Trial Organization | 30 | 2004-05-01 | 2013-05-30 |
Lung Neoplasms (2) · Breast Neoplasms (1) · Multiple Myeloma (1) · Small Cell Lung Carcinoma (1)
Celgene (1) · Japan Multinational Trial Organization (1) · Lawrence Einhorn (1) · Michaela Liedtke (1) · SCRI Development Innovations, LLC (1)
United States (4) · Japan (1)
Denise A. Yardley, M.D. (1) · Lawrence Einhorn, M.D. (1) · Markus Renschler, MD (1) · Michaela Liedtke (1) · Tadashi Mio, MD (1)